John Duncan Higgons
CIK 1581954 · Chief Operating Officer · last filed 2022-06-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.56M
Companies
2
Total Filings
46
Lifetime Open-Market Net
-$21.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. (JNCE) Delisted | Director | 9,713 | $1.88 | $18.3K | $67.9K | 12 | 2022-06-28 |
| AGIO | Chief Operating Officer | 120,834 | $29.46 | $3.56M | -$21.43M | 34 | 2016-01-05 |
Recent Filings · Page 5 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-12 | AGIO | Exer (M) | +20,000 | $6.0K | EDGAR |
| 2014-03-07 | AGIO | Mixed | — | -$602.1K | EDGAR |
| 2014-03-04 | AGIO | Mixed | — | -$236.4K | EDGAR |
| 2014-02-20 | AGIO | Mixed | — | -$81.8K | EDGAR |
| 2014-02-04 | AGIO | Mixed | — | -$205.3K | EDGAR |
| 2014-01-23 | AGIO | Mixed | — | -$412.9K | EDGAR |
Showing 41–46 of 46
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.